Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...

Famciclovir. A prodrug of penciclovir, famciclovir does not have a major role in the treatment of chronic hepatitis B because of its low efficacy compared with lamivudine. Adefovir dipivoxil.

The main goals of chronic hepatitis B treatment should be the long-term suppression of viral replication to minimize disease progression and the risk for the development of hepatocellular carcinoma.

These findings offer new hope for patients undergoing long-term antiviral treatment for hepatitis B. More information: Hyung Joon Yim et al, Switching to Besifovir in Patients with Chronic ...

Liver fibrosis is a key process in the progression of chronic liver diseases. However, there are currently no drugs ...

The company is dedicated to educating patients, providers, and others on new findings in chronic hepatitis B virus (HBV ... HBV infection is life-long treatment and does not eliminate the virus ...

Treatment against hepatitis B was included in the programme in 2019. The Delhi government's initiative was to raise awareness about the viral disease. "For hepatitis, prevention is truly better ...

SEOUL, South Korea, April 9, 2025 /PRNewswire/ -- Chronic hepatitis B (CHB) is currently estimated ... most widely used antiviral agent for CHB treatment. However, long-term use of TDF has adverse ...

These findings promise new hope for patients undergoing long-term antiviral treatment for hepatitis B. Reference: Yim HJ, Seo YS, Kim JH, et al. Switching to besifovir in patients with chronic ...

These findings promise new hope for patients undergoing long-term antiviral treatment for hepatitis B! Korea University College of Medicine is the medical school of Korea University. It is located ...

SEOUL, South Korea, April 9, 2025 /PRNewswire/ -- Chronic hepatitis B (CHB) is currently estimated to affect over 250 million people worldwide, and tenofovir disoproxil fumarate (TDF) is currently the ...